Similar articles

• Insulin-like growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation.

  Robitaille R, Dusseault J, Henley N, Rosenberg L, Hallé JP. Robitaille R, et al. Endocrinology. 2003 Jul;144(7):3037-45. doi: 10.1210/en.2002-0185. Endocrinology. 2003. PMID: 12810560
• Inhibition of inflammatory cytokine-induced response in human islet cells by withaferin A.

  Peng H, Olsen G, Tamura Y, Noguchi H, Matsumoto S, Levy MF, Naziruddin B. Peng H, et al. Transplant Proc. 2010 Jul-Aug;42(6):2058-61. doi: 10.1016/j.transproceed.2010.05.131. Transplant Proc. 2010. PMID: 20692407
• c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.

  Varona-Santos JL, Pileggi A, Molano RD, Sanabria NY, Ijaz A, Atsushi M, Ichii H, Pastori RL, Inverardi L, Ricordi C, Fornoni A. Varona-Santos JL, et al. Diabetologia. 2008 Dec;51(12):2271-80. doi: 10.1007/s00125-008-1169-7. Epub 2008 Oct 14. Diabetologia. 2008. PMID: 18853132
• Effect of stable glutamine compounds on porcine islet culture.

  Brandhorst H, Duan Y, Iken M, Bretzel RG, Brandhorst D. Brandhorst H, et al. Transplant Proc. 2005 Oct;37(8):3519-20. doi: 10.1016/j.transproceed.2005.09.043. Transplant Proc. 2005. PMID: 16298648
• Rapid assessment of islet cell viability by MTT assay after cold storage in different solutions.

  Kumar P, Delfino V, McShane P, Gray DW, Morris PJ. Kumar P, et al. Transplant Proc. 1994 Apr;26(2):814. Transplant Proc. 1994. PMID: 8171672 No abstract available.